M. Brawner Floyd
- Organic Chemistry top 2%
- Quinazolinone synthesis and applications 9
- Synthesis and biological activity 5
- Synthesis and Characterization of Heterocyclic Compounds 3
- Oncology top 5%
- HER2/EGFR in Cancer Research 9
- Genetics top 5%
- Molecular Biology top 10%
- Chemical Synthesis and Analysis 4
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Kinase Regulation and GTPase Signaling 3
-
- Inflammatory mediators and NSAID effects 5
- Co-authors
- Bernard D. JohnsonAllan WissnerRamaswamy NilakantanRu ShenHwei‐Ru TsouMarvin F. ReichSridhar K. RabindranCarolyn Discafani
- Cited by
- Organic ChemistryOncologyGenetics
- Journals
- Journal of the American Chemical Society (4 papers)Cancer Research (2 papers)Journal of Medicinal Chemistry (9 papers)
- Partner nations
- United StatesCanada
In The Last Decade
M. Brawner Floyd
40 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Organic Chemistry 1.1k
- Oncology 921
- Genetics 171
- Molecular Biology 926
- Pulmonary and Respiratory Medicine 425
Countries citing papers authored by M. Brawner Floyd
This map shows the geographic impact of M. Brawner Floyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brawner Floyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brawner Floyd more than expected).
Fields of papers citing papers by M. Brawner Floyd
This network shows the impact of papers produced by M. Brawner Floyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brawner Floyd. The network helps show where M. Brawner Floyd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Brawner Floyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 82 | |
| 2 | 2009 | 21 | |
| 3 | 2007 | 62 | |
| 4 | 2005 | 246 | |
| 5 | 2003 | 25 | |
| 6 | 2002 | 212 | |
| 7 | 2002 | 54 | |
| 8 | 2001 | 1 | |
| 9 | 2000 | 58 | |
| 10 | 1999 | 84 | |
| 11 | 1982 | 15 | |
| 12 | 1979 | 14 | |
| 13 | 1979 | 144 | |
| 14 | 1978 | 22 | |
| 15 | 1974 | 12 | |
| 16 | 1973 | 10 | |
| 17 | 1970 | 0 | |
| 18 | 1970 | 12 | |
| 19 | 1970 | 10 | |
| 20 | 1963 | 16 |
About M. Brawner Floyd
M. Brawner Floyd is a scholar working on Organic Chemistry, Pharmacology and Oncology, having authored 41 papers that have together received 2.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Quinazolinone synthesis and applications (9 papers), Synthesis and biological activity (5 papers), Inflammatory mediators and NSAID effects (5 papers), Chemical Synthesis and Analysis (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Organic Chemistry (1.1k citations), Oncology (921 citations) and Genetics (171 citations). M. Brawner Floyd has collaborated with scholars based in United States and Canada. Frequent co-authors include Bernard D. Johnson, Allan Wissner, Ramaswamy Nilakantan, Ru Shen, Hwei‐Ru Tsou, Marvin F. Reich, Sridhar K. Rabindran, Carolyn Discafani, Yu‐Fen Wang and William Hallett. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.